Effects of brown rice and white rice on expression of xenobiotic metabolism genes in type 2 diabetic rats

International Journal of Molecular Sciences

Volumn 13, Issue 7, 2012, Pages 8597-8608

  Imam, Mustapha Umar ^a   Ismail, Maznah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Cytochrome P450; Drug biotransformation; Gene expression; Rice

Indexed keywords

CYTOCHROME P450 2B1; CYTOCHROME P450 2C11; CYTOCHROME P450 2E1; CYTOCHROME P450 3A1; CYTOCHROME P450 4A1; GLUCOSE; METFORMIN; STREPTOZOCIN; UNSPECIFIC MONOOXYGENASE;

ALD1A1 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROWN RICE; CONTROLLED STUDY; CYP2B1 GENE; CYP2C11 GENE; CYP2C6 GENE; CYP2D4 GENE; CYP2E1 GENE; CYP3A1 GENE; CYP4A1 GENE; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; LIPID DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; RICE; UGT2B1 GENE; UPREGULATION; WHITE RICE; XENOBIOTIC METABOLISM; ANIMAL; COMPARATIVE STUDY; DIET; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLYCEMIC INDEX; LIVER; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET; GENE EXPRESSION; GLYCEMIC INDEX; LIVER; MALE; ORYZA SATIVA; RATS, SPRAGUE-DAWLEY;

EID: 84864352412     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13078597     Document Type: Article

References (34)

1. Xu, C.; Li, C.Y.T.; Kong, A.N.T. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 2005, 28, 249-268.
2. World Health Organization. Diabetes fact sheet. Available online: http://www.who.int/mediacentre/factsheets/fs312/en/index.html (accessed on 2 June 2012).
3. Stumvoll, M.; Goldstein, B.J.; van Haeften, T.W. Type 2 diabetes: Principles of pathogenesis and therapy. Lancet 2005, 365, 1333-1346.
4. Lewis, D.F. 57 varieties: The human cytochromes P450. Pharmacogenomics 2004, 5, 305-318.
5. Barnett, C.R.; Flatt, P.R.; Ioannides, C. Modulation of the rat hepatic cytochrome P450 composition by long-term streptozotocin-induced insulin-dependent diabetes. J. Biochem. Toxicol. 1994, 2, 63-69.
6. Nobuo, S. Cytochrome P450 changes in rats with streptozocin-induced diabetes. Int. J. Biochem. 1994, 26, 1261-1268.
7. Sakuma, T.; Honma, R.; Maguchi, S.; Tamaki, H.; Nemoto, N. Different expression of hepatic and renal cytochrome P450s between the streptozotocininduced diabetic mouse and rat. Xenobiotica 2001, 4, 223-237.
8. Shimojo, N.; Ishizaki, T.; Imaoka, S.; Funae, Y.; Fuji, S.; Okuda, K. Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Biochem. Pharmacol. 1993, 46, 621-627.
9. Wang, Z.; Hall, S.D.; Maya, J.F.; Li, L.; Asghar, A.; Gorski, J.C. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br. J. Clin. Pharmacol. 2003, 55, 77-85.
10. Khush, G. Productivity improvements in rice. Nutr. Rev. 2003, 61, S114-S116.
11. Hu, E.A.; Pan, A.; Malik, V.; Sun, Q. White rice consumption and risk of type 2 diabetes: Meta-analysis and systematic review. Br. Med. J. 2012, 344, doi:10.1136/bmj.e1454.
12. Miller, J.B.; Pang, E.; Bramall, L. Rice: A high or low glycemic index food? Am. J. Clin. Nutr. 1992, 56, 1034-1036.
13. Panlasigui, L.N.; Thompson, L.U. Blood glucose lowering effects of brown rice in normal and diabetic subjects. Int. J. Food Sci. Nutr. 2006, 57, 151-158.
14. Sun, Q.; Donna, S.; Rob, M.V.D.; Michelle, D.H.; Vasanti, S.M.; Walter, C.W.; Frank, B.H. White rice, brown rice, and risk of type 2 diabetes in US men and women. Arch. Intern. Med. 2010, 170, 961-969.
15. Zhang, G.; Malik, V.S.; Pan, A.; Kumar, S.; Holmes, M.D.; Spiegelman, D.; Lin, X.; Hu, F.B. Substituting brown rice for white rice to lower diabetes risk: A focus-group study in Chinese adults. J. Am. Diet. Assoc. 2010, 110, 1216-1221.
16. Jenkins, D.J.A.; Kendall, C.W.C.; Augustin, L.S.A.; Franceschi, S.; Hamidi, M.; Marchie, A.; Jenkins, A.L.; Axelsen, M. Glycemic index: Overview of implications in health and disease. Am. J. Clin. Nutr. 2002, 76, 266-273.
17. Miller, A.; Engel, K.H. Content of γ-oryzanol and composition of steryl ferulates in brown rice (Oryza sativa L.) of European origin. J. Agric. Food Chem. 2006, 54, 8127-8133.
18. Lu, T.J.; Chen, H.N.; Wang, H.J. Chemical constituents, dietary fiber, and γ-oryzanol in six commercial varieties of brown rice from Taiwan. Cereal Chem. 2011, 88, 463-466.
19. Jayadeep, A.; Malleshi, N.G. Nutrients, composition of tocotrienols, tocopherols, and γ-oryzanol, and antioxidant activity in brown rice before and after biotransformation. CyTA J. Food 2011, 9, 82-87.
20. Roohinejad, S.; Mirhosseini, H.; Saari, N.; Mustafa, S.; Alias, I.; Shobirin, M.H.A.; Hamid, A.; Manap, M.Y. Evaluation of GABA, crude protein and amino acid composition from different varieties of Malaysian's brown rice. Aust. J. Crop Sci. 2009, 3, 184-190.
21. Hu, F.B.; van Dam, R.M.; Liu, S. Diet and risk of Type II diabetes: The role of types of fat and carbohydrate. Diabetologia 2001, 44, 805-817.
22. Ludwig, D.S.; Majzoub, J.A.; Al-Zahrani, A.; Dallal, G.E.; Blanco, I.; Roberts, S.B. High glycemic index foods, overeating, and obesity. Pediatrics 1999, 103, doi:10.1542/peds.103.3.e26.
23. Brand-Miller, J.; Hayne, S.; Petocz, P.; Colagiuri, S. Low-glycemic index diets in the management of diabetes: A meta-analysis of randomized controlled trials. Diabetes Care 2003, 26, 2261-2267.
24. Bailey, C.J.; Turner, R.C. Metformin. New Eng. J. Med. 1996, 334, 574-579.
25. Edenberg, H.J. The genetics of alcohol metabolism: Role of alcohol dehydrogenase and aldehyde. Alcohol. Res. Health 2007, 30, 5-13.
26. Ingelman-Sundberg, M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): Clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 2005, 5, 6-13.
27. Pelkonen, O.; Turpeinen, M.; Hakkola, J.; Honkakoski, P.; Hukkanen, J.; Raunio, H. Inhibition and induction of human cytochrome P450 enzymes: Current status. Arch. Toxicol. 2008, 82, 667-715.
28. Mitschke, D.; Reichel, A.; Fricker, G.; Moenning, U. Characterization of cytochrome P450 protein expression along the entire length of the intestine of male and female rats. Drug Metab. Dispos. 2008, 36, 1039-1045.
29. Schmider, J.; Greenblatt, D.J.; von Moltke, L.L.; Karsov, D.; Shader, R.I. Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: Studies of phenytoin p-hydroxylation. Br. J. Clin. Pharmacol. 1997, 44, 495-498.
30. Caraco, Y.; Muszkat, M.; Wood, A.J. Phenytoin metabolic ratio: A putative marker of CYP2C9 activity in vivo. Pharmacogenetics 2001, 11, 587-596.
31. Lee, C.R.; Pieper, J.A.; Frye, R.F.; Hinderliter, A.L.; Blaisdell, J.A.; Goldstein, J.A. Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humans. J. Clin. Pharmacol. 2003, 43, 84-91.
32. Owens, I.S.; Ritter, J.K.; Yeatman, M.T.; Chen, F. The novelUGT1 gene complex links bilirubin, xenobiotics, and therapeutic drug metabolism by encoding UDP-glucuronosyltransferase isozymes with a common carboxyl terminus. J. Pharmacokinet Biopharm. 1996, 24, 491-508.
33. Levin, B.E.; Hogan, S.; Sullivan, A.C. Initiation and perpetuation of obesity and obesity resistance in rats. Am. J. Physiol. 1989, 256, R766-R771.
34. Srinivasan, K.; Viswanad, B.; Asrat, L.; Kaul, C.L.; Ramarao, P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 2005, 52, 313-320.